Electroencephalogram
An electroencephalogram (EEG) is a neurophysiological measurement that records the electrical activity of the brain. It is a non-invasive procedure that involves placing electrodes on the scalp to detect the tiny electrical impulses generated by brain cells. These electrical signals are amplified and displayed as wave patterns, providing insights into brain function.
Biological Basis
The biological basis of the electroencephalogram lies in the synchronized electrical activity of large populations of neurons in the brain. Neurons communicate through electrochemical signals. When many neurons fire in unison, they generate measurable electrical potentials that can propagate through brain tissue, cerebrospinal fluid, skull, and scalp. The EEG electrodes detect these voltage fluctuations, which are primarily generated by postsynaptic potentials in the pyramidal neurons of the cerebral cortex. Different mental states, such as wakefulness, sleep, or specific cognitive tasks, are associated with distinct patterns of brain waves, characterized by their frequency, amplitude, and morphology.
Clinical Relevance
The electroencephalogram is a vital diagnostic tool in clinical neurology. It is widely used to evaluate and diagnose various neurological conditions, most notably epilepsy, by detecting abnormal brain electrical discharges that characterize seizures. EEG can also help in diagnosing sleep disorders, assessing the level of consciousness in comatose patients, confirming brain death, and evaluating brain function in conditions like encephalitis, stroke, or tumors. The patterns observed in an EEG can provide crucial information about the location and nature of brain dysfunction.
Social Importance
Beyond its clinical applications, the electroencephalogram holds significant social importance in understanding the human brain and its disorders. It has contributed to our fundamental knowledge of brain development, sleep cycles, and cognitive processes. Research using EEG has advanced fields such as cognitive neuroscience, psychology, and human-computer interaction. It offers a window into the brain's real-time activity, facilitating the study of mental health conditions and contributing to the development of therapies and interventions. The non-invasive nature and relative affordability of EEG make it an accessible tool for both clinical practice and scientific inquiry, impacting patient care and broader scientific understanding.
Variants
Genetic variations play a crucial role in shaping biological processes, including those underlying neurological function and brain activity as measured by electroencephalogram (EEG). The single nucleotide polymorphism (SNP) rs984924 is located within the PRKG2 gene, which encodes cGMP-dependent protein kinase 2. This enzyme is primarily known for its involvement in ion transport and fluid homeostasis, particularly in the intestine, but it also plays a role in neuronal signaling pathways, influencing neurotransmitter release and synaptic plasticity. Alterations in these pathways due to variants in PRKG2 could potentially affect brain excitability and connectivity, which are fundamental to EEG patterns. Similarly, rs17055223 in the PTPRK gene, encoding protein tyrosine phosphatase receptor type K, may impact neuronal development and function. PTPRK is involved in cell adhesion, growth, and differentiation, processes vital for the proper formation and maintenance of neural circuits, and its modulation by genetic variants could contribute to differences in brain electrical activity. [1]
Other variants influence genes involved in protein modification and membrane function. The METTL21C gene, associated with rs9514041 and rs9518810, codes for a methyltransferase enzyme, which catalyzes the addition of methyl groups to proteins. This post-translational modification can significantly alter protein function, stability, and interactions, including those critical for neuronal signaling and synaptic integrity. Disruptions in these processes, potentially mediated by such variants, could lead to subtle or pronounced changes in brain network activity detectable by EEG. [2] The PCNX2 gene, linked to rs1159970, encodes Pecanex homolog 2, a transmembrane protein. Transmembrane proteins are essential for cell membrane structure and function, including the transport of ions and molecules across neuronal membranes, which is crucial for generating and propagating electrical signals in the brain. Variants affecting PCNX2 could therefore modulate neuronal excitability and signal transduction, impacting the synchronized electrical rhythms observed in EEG. [3]
Structural and regulatory genes also harbor variants with potential neurological implications. The DMD gene, associated with rs145793786 along with FAM47A, encodes dystrophin, a vital protein for muscle cell integrity and also for proper brain function. Although primarily known for its role in muscular dystrophies, dystrophin's presence in neurons suggests a role in maintaining neuronal structure and synaptic function. Variants in DMD can lead to neurological comorbidities that affect cognitive function and brain electrical activity. [4] The CMYA5 gene, associated with rs6867021 alongside LINC01455, encodes a myosin-associated protein. While CMYA5 is typically related to muscle biology, its co-localization with LINC01455, a long intergenic non-coding RNA, suggests broader regulatory functions. Such regulatory elements can influence the expression of genes critical for various cellular processes, including those in the brain, potentially contributing to variations in neurological traits and EEG patterns. [5]
Furthermore, variants in developmental and scaffolding proteins, as well as several lincRNAs, contribute to the genetic landscape of brain function. The DBX1 gene, linked to rs7119037 with HTATIP2, is a homeobox gene crucial for specifying neuronal cell types and patterning in the developing central nervous system. Variants in DBX1 could significantly impact brain architecture and the establishment of functional neural circuits, leading to observable differences in EEG. Similarly, SH3BP4, associated with rs11677128 and LINC01173, encodes an SH3 domain binding protein involved in endosomal trafficking and membrane protein recycling, processes essential for synaptic vesicle dynamics and neurotransmission. Long intergenic non-coding RNAs, such as LINC00996 (rs10231372) and LINC01331 (rs146159092), are increasingly recognized as key regulators of gene expression, chromatin structure, and cellular differentiation. Variants in these non-coding regions can subtly alter the expression of nearby or distant genes, impacting neuronal communication and brain electrical activity. [6]
Key Variants
| RS ID | Gene | Related Traits |
|---|---|---|
| rs10231372 | LINC00996 | electroencephalogram measurement |
| rs984924 | PRKG2 | electroencephalogram measurement |
| rs1159970 | PCNX2 | electroencephalogram measurement |
| rs9514041 rs9518810 |
METTL21C | electroencephalogram measurement |
| rs6867021 | CMYA5 - LINC01455 | electroencephalogram measurement |
| rs17055223 | PTPRK | electroencephalogram measurement |
| rs11677128 | LINC01173 - SH3BP4 | electroencephalogram measurement |
| rs7119037 | DBX1 - HTATIP2 | electroencephalogram measurement |
| rs145793786 | DMD - FAM47A | electroencephalogram measurement |
| rs146159092 | LINC01331 | electroencephalogram measurement |
Genetic Basis of Physiological Traits
Physiological traits often exhibit a significant degree of heritability, indicating that genetic factors play a crucial role in their expression. Genome-wide association studies (GWAS) are instrumental in identifying specific genetic variants, such as single nucleotide polymorphisms (SNPs), that are associated with these complex phenotypes . These studies aim to uncover the underlying genetic architecture influencing various biological characteristics, with findings often indicating pleiotropic effects where a single genetic variant may influence multiple related traits . Such investigations provide insights into the genetic correlates of traits and can help delineate pathways affected by specific genetic variations. [7]
Molecular Pathways and Key Biomolecules
Numerous genes encode critical biomolecules that regulate cellular functions and metabolic processes. For instance, genes like ACE, AGT, AGTR1, ADRB1, VEGF, and NOS3 are known to be involved in pathways related to vascular regulation and hemodynamic responses . These genes can produce enzymes, receptors, and signaling proteins that contribute to complex regulatory networks within the body. Additionally, specific gene variants, such as common SNPs in HMGCR, have been shown to affect molecular processes like alternative splicing, which in turn can influence the levels of key biomolecules like LDL-cholesterol. [8]
Tissue-Level Physiology and Homeostasis
The interplay of genetic and molecular mechanisms manifests at the tissue and organ level, influencing organ-specific functions and overall systemic homeostasis. For example, traits such as left ventricular (LV) chamber size, wall thickness, and mass are critical indicators of cardiac remodeling, while brachial artery (BA) flow-mediated dilation (FMD) reflects endothelial function . These physiological measures are subject to genetic influences and can serve as intermediate phenotypes, reflecting the integrated function of various tissues and their responses to environmental and genetic factors .
Pathophysiological Mechanisms
Disruptions in molecular and cellular pathways can lead to pathophysiological processes, contributing to the development of various health conditions. For instance, alterations in LV remodeling and mass are fundamental to the pathogenesis of high blood pressure and are associated with a higher risk of clinical cardiovascular disease (CVD), including stroke and heart failure . Similarly, endothelial dysfunction, often assessed through BA FMD, is recognized as a precursor to atherosclerosis and overt CVD . Understanding these mechanisms helps in identifying individuals at risk and in characterizing the progression of disease.
References
[1] Benjamin EJ, et al. "Genome-wide association with select biomarker traits in the Framingham Heart Study." BMC Med Genet, vol. 8, suppl. 1, 2007, p. S11.
[2] O'Donnell CJ, et al. "Genome-wide association study for subclinical atherosclerosis in major arterial territories in the NHLBI's Framingham Heart Study." BMC Med Genet, vol. 8, suppl. 1, 2007, p. S4.
[3] Kathiresan S, et al. "Common variants at 30 loci contribute to polygenic dyslipidemia." Nat Genet, vol. 40, no. 2, 2008, pp. 189-197.
[4] Wilk JB, et al. "Framingham Heart Study genome-wide association: results for pulmonary function measures." BMC Med Genet, vol. 8, suppl. 1, 2007, p. S8.
[5] Yang Q, et al. "Genome-wide association and linkage analyses of hemostatic factors and hematological phenotypes in the Framingham Heart Study." BMC Med Genet, vol. 8, suppl. 1, 2007, p. S12.
[6] Hwang SJ, et al. "A genome-wide association for kidney function and endocrine-related traits in the NHLBI's Framingham Heart Study." BMC Med Genet, vol. 8, suppl. 1, 2007, p. S10.
[7] Gieger, C et al. "Genetics meets metabolomics: a genome-wide association study of metabolite profiles in human serum." PLoS Genet, vol. 4, no. 11, 2008, p. e1000282.
[8] Burkhardt, R et al. "Common SNPs in HMGCR in micronesians and whites associated with LDL-cholesterol levels affect alternative splicing of exon13." Arterioscler Thromb Vasc Biol, 2009.